Brian Schwartz | Chief Medical Officer
Arqule, Inc.

Brian Schwartz, Chief Medical Officer, Arqule, Inc.

Dr. Schwartz joined ArQule 2008 and is currently CMO and Head of Research and Development. More than two decades of experience in pharmaceutical and biotechnology industries, spanning a number of therapeutic areas including oncology, dermatology, neurology and rare diseases. The majority of his achievements are in oncology, encompassing the development of targeted and cytotoxic agents and immunotherapy.  Accumulated a series of successes in Biotech and Pharma companies(Ziopharm, Bayer and Leo Pharma) that served as a solid foundation, leading to initiatives in US based cancer/rare disease focused biotechnology companies. Recruited into several senior executive level roles during course of his career where he managed diverse interdisciplinary teams to produce a number of successful New Drug Applications (NDA), numerous Investigational New Drug (IND) applications, preclinical and clinical drug development programs. . Received his medical degree from the University of Pretoria, South Africa, practiced medicine, and worked at the University of Toronto prior to his career in industry


World Orphan Drug Congress USA 2018 - Conference Day Two @ 14:40

The Use of AKT Inhibitors in rare overgrowth syndromes

back to speakers